Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus

World Journal of Gastroenterology

Volumn 12, Issue 19, 2006, Pages 2846-2857

  Zhao, Jing Bo ^a,b   Frøkjær, Jens Brøndum ^a,b   Drewes, Asbjørn Mohr ^a,b   Ejskjaer, Niels ^c  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diabetes; Diabetic neuropathy; Esophagus; Hyperglycemia; Intestine; Motility; Pain; Remodeling; Stomach

Indexed keywords

AUTONOMIC NEUROPATHY; BIOMECHANICS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE DURATION; DISEASE SEVERITY; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL TRANSIT; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MORPHOLOGY; MOTOR DYSFUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SENSORY DYSFUNCTION; UPPER GASTROINTESTINAL TRACT;

EID: 33744500487     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i18.2846     Document Type: Review

References (173)

1. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003; 26: 917-932
2. Folwaczny C, Riepl R, Tschop M, Landgraf R. Gastrointestinal involvement in patients with diabetes mellitus: Part I (first of two parts). Epidemiology, pathophysiology, clinical findings. Z Gastroenterol 1999; 37: 803-815
3. Verne GN, Sninsky CA. Diabetes and the gastrointestinal tract. Gastroenterol Clin North Am 1998; 27: 861-874, vi-vii
4. Horowitz M, Samsom M. Gastrointestinal function in diabetes mellitus. Chichester: John Wiley & Sons, Ltd, 2004: 1-337
5. Kamath MV, Tougas G, Fitzpatrick D, Fallen EL, Watteel R, Shine G, Upton AR. Assessment of the visceral afferent and autonomic pathways in response to esophageal stimulation in control subjects and in patients with diabetes. Clin Invest Med 1998; 21: 100-113
6. Kamath MV, May A, Hollerbach S, Fitzpatrick D, Bulat R, Bajwa A, Tougas G, Fallen EL, Shine G, Upton AR. Effects of esophageal stimulation in patients with functional disorders of the gastrointestinal tract. Crit Rev Biomed Eng 2000; 28: 87-93
7. Rathmann W, Enck P, Frieling T, Gries FA. Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care 1991; 14: 1086-1089
8. Mayhew TM, Carson FL, Sharma AK. Small intestinal morphology in experimental diabetic rats: a stereological study on the effects of an aldose reductase inhibitor (ponalrestat) given with or without conventional insulin therapy. Diabetologia 1989; 32: 649-654
9. Tahara T, Yamamoto T. Morphological changes of the villous microvascular architecture and intestinal growth in rats with streptozotocin-induced diabetes. Virchows Arch A Pathol Anat Histopathol 1988; 413: 151-158
10. Zoubi SA, Mayhew TM, Sparrow RA. The small intestine in experimental diabetes: cellular adaptation in crypts and villi at different longitudinal sites. Virchows Arch 1995; 426: 501-507
11. Charlton M, Ahlman B, Nair KS. The effect of insulin on human small intestinal mucosal protein synthesis. Gastroenterology 2000; 118: 299-306
12. Jorgensen CS, Ahrensberg JM, Gregersen H, Flyvberg A. Tension-strain relations and morphometry of rat small intestine in experimental diabetes. Dig Dis Sci 2001; 46: 960-967
13. Yang J, Zhao J, Zeng Y, Gregersen H. Biomechanical properties of the rat oesophagus in experimental type-1 diabetes. Neurogastroenterol Motil 2004; 16: 195-203
14. Zhao J, Sha H, Zhou S, Tong X, Zhuang FY, Gregersen H. Remodelling of zero-stress state of small intestine in streptozotocin-induced diabetic rats. Effect of gliclazide. Dig Liver Dis 2002; 34: 707-716
15. Zhao J, Yang J, Gregersen H. Biomechanical and morphometric intestinal remodelling during experimental diabetes in rats. Diabetologia 2003; 46: 1688-1697
16. Zhao J, Liao D, Yang J, Gregersen H. Viscoelastic behavior of small intestine in streptozotocin-induced diabetic rats. Dig Dis Sci 2003; 48: 2271-2277
17. Liao D, Zhao J, Gregersen H. Three-dimensional geometry analysis of the stomach in type II diabetic GK rats. Diabetes Res Clin Pract 2006; 71: 1-13
18. Zhao J, Liao D, Gregersen H. Biomechanical and histomorphometric esophageal remodeling in type-2 diabetic GK rats. Journal of Diabetes and its Complications 2006; in press
19. Frokjaer JB, Andersen SD, Ejskjaer N, Funch-Jensen P, Drewes AM, Gregersen H. Biomechanical Remodeling and Impaired Contractility of the Upper Gastrointestinal Tract in Diabetes Mellitus. Gastroenterology 2006; Submitted
20. Camilleri M. Gastrointestinal problems in diabetes. Endocrinol Metab Clin North Am 1996; 25: 361-378
21. Horowitz M, Fraser R. Disordered gastric motor function in diabetes mellitus. Diabetologia 1994; 37: 543-551
22. Talley NJ, Young L, Bytzer P, Hammer J, Leemon M, Jones M, Horowitz M. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol 2001; 96: 71-76
23. Talley NJ, Howell S, Jones MP, Horowitz M. Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2002; 97: 3087-3094
24. Schvarcz E, Palmer M, Ingberg CM, Aman J, Berne C. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med 1996; 13: 478-481
25. Maleki D, Locke GR 3rd, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, Melton LJ 3rd. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000; 160: 2808-2816
26. Ko GT, Chan WB, Chan JC, Tsang LW, Cockram CS. Gastrointestinal symptoms in Chinese patients with Type 2 diabetes mellitus. Diabet Med 1999; 16: 670-674
27. Spangeus A, El-Salhy M, Suhr O, Eriksson J, Lithner F. Prevalence of gastrointestinal symptoms in young and middle-aged diabetic patients. Scand J Gastroenterol 1999; 34: 1196-1202
28. Ricci JA, Siddique R, Stewart WF, Sandler RS, Sloan S, Farup CE. Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes. Scand J Gastroenterol 2000; 35: 152-159
29. Smith DS, Ferris CD. Current concepts in diabetic gastroparesis. Drugs 2003; 63: 1339-1358
30. Rayner CK, Horowitz M. New management approaches for gastroparesis. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 454-462; quiz 493
31. Umpierrez G, Freire AX. Abdominal pain in patients with hyperglycemic crises. J Crit Care 2002; 17: 63-67
32. Longstreth GF. Diabetic thoracic polyradiculopathy: ten patients with abdominal pain. Am J Gastroenterol 1997; 92: 502-505
33. Samsom M, Verhagen MAMT. Intestinal function. In: Horowitz M, Samsom M, eds. Gastrointestinal function in diabetes mellitus. Chichester: John Wiley & Sons, Ltd, 2004: 177-218
34. Virally-Monod M, Tielmans D, Kevorkian JP, Bouhnik Y, Flourie B, Porokhov B, Ajzenberg C, Warnet A, Guillausseau PJ. Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab 1998; 24: 530-536
35. Zietz B, Lock G, Straub RH, Braun B, Scholmerich J, Palitzsch KD. Small-bowel bacterial overgrowth in diabetic subjects is associated with cardiovascular autonomic neuropathy. Diabetes Care 2000; 23: 1200-1201
36. Anderson RP. Coeliac disease. Aust Fam Physician 2005; 34: 239-242
37. Smout AJPM. Oesophageal function. In: Horowitz M, Samsom M, eds. Gastrointestinal function in diabetes mellitus. Chichester: John Wiley & Sons, Ltd, 2004: 97-116
38. Kong MF, Horowitz M. Diabetic gastroparesis. Diabet Med 2005; 22 Suppl 4: 13-18
39. Rayner CK, Verhagen MA, Hebbard GS, DiMatteo AC, Doran SM, Horowitz M. Proximal gastric compliance and perception of distension in type 1 diabetes mellitus: effects of hyperglycemia. Am J Gastroenterol 2000; 95: 1175-1183
40. Undeland KA, Hausken T, Gilja OH, Aanderud S, Berstad A. Gastric meal accommodation and symptoms in diabetes. A placebo-controlled study of glyceryl trinitrate. Eur J Gastroenterol Hepatol 1998; 10: 677-681
41. Frokjaer JB, Andersen SN, Ejskjaer N, Funch-Jensen P, Lars Arendt-Nielsen L, Gregersen H, Drewes AM. Visceral Sensation in Diabetic Autonomic Neuropathy. Gut 2006; Submitted
42. Rothstein RD. Gastrointestinal motility disorders in diabetes mellitus. Am J Gastroenterol 1990; 85: 782-785
43. Horowitz M, Maddox AF, Wishart JM, Harding PE, Chatterton BE, Shearman DJ. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991; 18: 229-234
44. Jorgensen F, Boesen F, Andersen EB, Hesse B. Oesophageal transit in patients with autonomic dysfunction. The effect of treatment with fludrocortisone. Clin Physiol 1991; 11: 83-92
45. Keshavarzian A, Iber FL, Nasrallah S. Radionuclide esophageal emptying and manometric studies in diabetes mellitus. Am J Gastroenterol 1987; 82: 625-631
46. Stewart IM, Hosking DJ, Preston BJ, Atkinson M. Oesophageal motor changes in diabetes mellitus. Thorax 1976; 31: 278-283
47. Tsai SC, Kao CH, Pan DY, ChangLai SP, Wang SJ. Effects of oral erythromycin on esophageal motility in patients with noninsulin-dependent diabetes mellitus. Gaoxiong Yixue Kexue Zazhi 1995; 11: 430-435
48. Annese V, Bassotti G, Caruso N, De Cosmo S, Gabbrielli A, Modoni S, Frusciante V, Andriulli A. Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol 1999; 29: 171-177
49. Holloway RH, Tippett MD, Horowitz M, Maddox AF, Moten J, Russo A. Relationship between esophageal motility and transit in patients with type I diabetes mellitus. Am J Gastroenterol 1999; 94: 3150-3157
50. Chang FY, Doong ML, Chen TS, Lee SD, Wang PS. Altered intestinal transit is independent of gastroparesis in the early diabetic rats. Chin J Physiol 1997; 40: 31-35
51. Yamano M, Kamato T, Nagakura Y, Miyata K. Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 1997; 356: 145-150
52. Mehta N, Veliath S, Thombre DP. Effect of experimental diabetes and vagotomy on gastric emptying in rats. Indian J Physiol Pharmacol 2002; 46: 441-448
53. Ogata M, Uchimura T, Iizuka Y, Murata R, Suzuki S, Toyota T, Hikichi N. Effect of non-insulin dependent diabetes on cyclosporin A disposition in Goto-Kakizaki (GK) rats. Biol Pharm Bull 1997; 20: 1026-1029
54. Liu J, Qiao X, Micci MA, Pasricha PJ, Chen JD. Improvement of gastric motility with gastric electrical stimulation in STZ-induced diabetic rats. Digestion 2004; 70: 159-166
55. Le Blanc-Louvry I, Guerre F, Songne B, Ducrotte P. Gastric stimulation: influence of electrical parameters on gastric emptying in control and diabetic rats. BMC Surg 2002; 2: 5
56. Ogata M, Iizuka Y, Murata R, Hikichi N. Effect of streptozotocin-induced diabetes on cyclosporin A disposition in rats. Biol Pharm Bull 1996; 19: 1586-1590
57. Young AA, Gedulin B, Vine W, Percy A, Rink TJ. Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 1995; 38: 642-648
58. Nowak TV, Roza AM, Weisbruch JP, Brosnan MR. Accelerated gastric emptying in diabetic rodents: effect of insulin treatment and pancreas transplantation. J Lab Clin Med 1994; 123: 110-116
59. Granneman JG, Stricker EM. Food intake and gastric emptying in rats with streptozotocin-induced diabetes. Am J Physiol 1984; 247: R1054-R1061
60. Horowitz M, Wishart JM, Jones KL, Hebbard GS. Gastric emptying in diabetes: an overview. Diabet Med 1996; 13: S16-S22
61. Horowitz M, Su YC, Rayner CK, Jones KL. Gastroparesis: prevalence, clinical significance and treatment. Can J Gastroenterol 2001; 15: 805-813
62. Jones KL, Horowitz M, Wishart MJ, Maddox AF, Harding PE, Chatterton BE. Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus. J Nucl Med 1995; 36: 2220-2228
63. Urbain JL, Vekemans MC, Bouillon R, Van Cauteren J, Bex M, Mayeur SM, Van den Maegdenbergh V, Bataille G, Charkes ND, Malmud LS. Characterization of gastric antral motility disturbances in diabetes using a scintigraphic technique. J Nucl Med 1993; 34: 576-581
64. Samsom M, Roelofs JM, Akkermans LM, van Berge Henegouwen GP, Smout AJ. Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy. Dig Dis Sci 1998; 43: 491-496
65. Chang FY, Lee SD, Yeh GH, Wang PS. Hyperglycaemia is responsible for the inhibited gastrointestinal transit in the early diabetic rat. Acta Physiol Scand 1995; 155: 457-462
66. Kumar MS, Prashanth KV. alpha-Lipoic acid ameliorates altered colonic contractility and intestinal transit in STZ-diabetic rats. Indian J Exp Biol 2004; 42: 279-282
67. El-Salhy M. Gastrointestinal transit in nonobese diabetic mouse: an animal model of human diabetes type 1. J Diabetes Complications 2001; 15: 277-284
68. El-Salhy M. Gastrointestinal transit in an animal model of human diabetes type 2: relationship to gut neuroendocrine peptide contents. Ups J Med Sci 2002; 107: 101-110
69. Anjaneyulu M, Ramarao P. Studies on gastrointestinal tract functional changes in diabetic animals. Methods Find Exp Clin Pharmacol 2002; 24: 71-75
70. Scarpello JH, Greaves M, Sladen GE. Small intestinal transit in diabetics. Br Med J 1976; 2: 1225-1226
71. de Boer SY, Masclee AA, Iam WF, Schipper J, Jansen JB, Lamers CB. Hyperglycemia modulates gallbladder motility and small intestinal transit time in man. Dig Dis Sci 1993; 38: 2228-2235
72. Iida M, Ikeda M, Kishimoto, M, Tsujino T, Kaneto, H, Matsuhisa M, Kajimoto Y, Watarai T, Yamasaki Y, Hori M. Evaluation of gut motility in type II diabetes by the radiopaque marker method. J Gastroenterol Hepatol 2000; 15: 381-385
73. Kawagishi T, Nishizawa Y, Okuno Y, Sekiya K, Morii H. Segmental gut transit in diabetes mellitus: effect of cisapride. Diabetes Res Clin Pract 1992; 17: 137-144
74. Folwaczny C, Hundegger K, Volger C, Sorodoc J, Kuhn M, Tatsch K, Landgraf R, Karbach U. Measurement of transit disorders in different gastrointestinal segments of patients with diabetes mellitus in relation to duration and severity of the disease by use of the metal-detector test. Z Gastroenterol 1995; 33: 517-526
75. Keshavarzian A, Iber FL, Dangleis MD, Cornish R. Intestinal-transit and lactose intolerance in chronic alcoholics. Am J Clin Nutr 1986; 44: 70-76
76. Nguyen HN, Silny J, Wuller S, Marschall HU, Rau G, Matern S. Abnormal postprandial duodenal chyme transport in patients with long standing insulin dependent diabetes mellitus. Gut 1997; 41: 624-631
77. Iber FL, Parveen S, Vandrunen M, Sood KB, Reza F, Serlovsky R, Reddy S. Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes. Dig Dis Sci 1993; 38: 45-50
78. Loo FD, Dodds WJ, Soergel KH, Arndorfer RC, Helm JF, Hogan WJ. Multipeaked esophageal peristaltic pressure waves in patients with diabetic neuropathy. Gastroenterology 1985; 88: 485-491
79. Borgstrom PS, Olsson R, Sundkvist G, Ekberg O. Pharyngeal and oesophageal function in patients with diabetes mellitus and swallowing complaints. Br J Radiol 1988; 61: 817-821
80. Belai A, Lefebvre RA, Burnstock G. Motor activity and neurotransmitter release in the gastric fundus of streptozotocin-diabetic rats. Eur J Pharmacol 1991; 194: 225-234
81. James AN, Ryan JP, Crowell MD, Parkman HP. Regional gastric contractility alterations in a diabetic gastroparesis mouse model: effects of cholinergic and serotoninergic stimulation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G612-G619
82. Korolkiewicz R, Rekowski P, Szyk A, Kato S, Yasuhiro T, Kubomi M, Tashima K, Takeuchi K. Effects of diabetes mellitus on the contractile activity of carbachol and galanin in isolated gastric fundus strips of rats. Pharmacology 1998; 57: 65-78
83. Sakai Y, Inazu M, Shamoto A, Zhu B, Homma I. Contractile hyperreactivity and alteration of PKC activity in gastric fundus smooth muscle of diabetic rats. Pharmacol Biochem Behav 1994; 49: 669-674
84. Bjornsson ES, Urbanavicius V, Eliasson B, Attvall S, Smith U, Abrahamsson H. Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand J Gastroenterol 1994; 29: 1096-1104
85. Samsom M, Jebbink RJ, Akkermans LM, van Berge-Henegouwen GP, Smout AJ. Abnormalities of antroduodenal motility in type I diabetes. Diabetes Care 1996; 19: 21-27
86. Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984; 14: 420-427
87. Dooley CP, el Newihi HM, Zeidler A, Valenzuela JE. Abnormalities of the migrating motor complex in diabetics with autonomic neuropathy and diarrhea. Scand J Gastroenterol 1988; 23: 217-223
88. Murray FE, Lombard MG, Ashe J, Lynch D, Drury MI, O'Moore B, Lennon J, Crowe J. Esophageal function in diabetes mellitus with special reference to acid studies and relationship to peripheral neuropathy. Am J Gastroenterol 1987; 82: 840-843
89. Clouse RE, Lustman PJ, Reidel WL. Correlation of esophageal motility abnormalities with neuropsychiatric status in diabetics. Gastroenterology 1986; 90: 1146-1154
90. Hollis JB, Castell DO, Braddom RL. Esophageal function in diabetes mellitus and its relation to peripheral neuropathy. Gastroenterology 1977; 73: 1098-1102
91. Ishiguchi T, Tada H, Nakagawa K, Yamamura T, Takahashi T. Hyperglycemia impairs antro-pyloric coordination and delays gastric emptying in conscious rats. Auton Neurosci 2002; 95: 112-120
92. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90: 1919-1925
93. Fraser R, Fried M, Beglinger C. Assessment of gastric emptying. Schweiz Med Wochenschr Suppl 1993; 54: 15-21
94. Jebbink HJ, Bravenboer B, Akkermans LM, vanBerge-Henegouwen GP, Smout AJ. Relationships between dyspeptic symptoms and gastrointestnal motility in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 948-954
95. Hebbard GS, Sun WM, Dent J, Horowitz M. Hyperglycaemia affects proximal gastric motor and sensory function in normal subjects. Eur J Gastroenterol Hepatol 1996; 8: 211-217
96. Hebbard GS, Samsom M, Sun WM, Dent J, Horowitz M. Hyperglycemia affects proximal gastric motor and sensory function during small intestinal triglyceride infusion. Am J Physiol 1996; 271: G814-G819
97. Hebbard GS, Samson M, Andrews JM, Carman D, Tansell B, Sun WM, Dent J, Horowitz M. Hyperglycemia affects gastric electrical rhythm and nausea during intraduodenal triglyceride infusion. Dig Dis Sci 1997; 42: 568-575
98. Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 24: 371-381
99. Lam WF, Masclee AA, Souverijn JH, Lamers CB. Effect of acute hyperglycemia on basal, secretin and secretin + cholecystokinin stimulated exocrine pancreatic secretion in humans. Life Sci 1999; 64: 617-626
100. Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 1988; 94: 739-744
101. Mizuno Y, Oomura Y. Glucose responding neurons in the nucleus tractus solitarius of the rat: in vitro study. Brain Res 1984; 307: 109-116
102. Liu M, Seino S, Kirchgessner AL. Identification and characterization of glucoresponsive neurons in the enteric nervous system. J Neurosci 1999; 19: 10305-10317
103. de Boer SY, Masclee AA, Lamers CB. Effect of hyperglycemia on gastrointestinal and gallbladder motility. Scand J Gastroenterol Suppl 1992; 194: 13-18
104. Samsom M, Akkermans LM, Jebbink RJ, van Isselt H, van-Berge-Henegouwen GP, Smout AJ. Gastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitus. Gut 1997; 40: 641-646
105. Jones KL, Horowitz M, Berry M, Wishart JM, Guha S. Blood glucose concentration influences postprandial fullness in IDDM. Diabetes Care 1997; 20: 1141-1146
106. Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983; 98: 378-384
107. Samsom M, Smout AJ. Abnormal gastric and small intestinal motor function in diabetes mellitus. Dig Dis 1997; 15: 263-274
108. Koch KL. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment. Dig Dis Sci 1999; 44: 1061-1075
109. Mearin F, De Ribot X, Balboa A, Antolin M, Varas MJ, Malagelada JR. Duodenogastric bile reflux and gastrointestinal motility in pathogenesis of functional dyspepsia. Role of cholecystectomy. Dig Dis Sci 1995; 40: 1703-1709
110. Mearin F, Malagelada JR. Gastroparesis and dyspepsia in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7: 717-723
111. Frokjaer JB, Andersen SD, Ejskjaer N, Funch-Jensen P, Drewes AM, Gregersen H. Biomechanical Remodeling and Impaired Contractility of the Upper Gastrointestinal Tract in Diabetes Mellitus. Gastroenterology 2006; Submitted
112. Belai A, Burnstock G. Changes in adrenergic and peptidergic nerves in the submucous plexus of streptozocin-diabetic rat ileum. Gastroenterology 1990; 98: 1427-1436
113. Belai A, Facer P, Bishop A, Polak JM, Burnstock G. Effect of streptozotocin-diabetes on the level of VIP mRNA in myenteric neurones. Neuroreport 1993; 4: 291-294
114. Belai A, Burnstock G. Acrylamide-induced neuropathic changes in rat enteric nerves: similarities with effects of streptozotocin-diabetes. J Auton Nerv Syst 1996; 58: 56-62
115. Di Giulio AM, Lesma E, Gorio A. Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P. J Neurosci Res 1995; 40: 414-419
116. Yagihashi S, Wada R, Kamijo M, Nagai K. Peripheral neuropathy in the WBN/ Kob rat with chronic pancreatitis and spontaneous diabetes. Lab Invest 1993; 68: 296-307
117. Yagihashi S, Kamijo M, Baba M, Yagihashi N, Nagai K. Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 1992; 41: 47-52
118. Yagihashi S, Zhang WX, Sima AA. Neuroaxonal dystrophy in distal symmetric sensory polyneuropathy of the diabetic BB-rat. J Diabet Complications 1989; 3: 202-210
119. Yagihashi S, Sima AA. Diabetic autononomic neuropathy. The distribution of structural changes in sympathetic nerves of the BB rat. Am J Pathol 1985; 121: 138-147
120. Schmidt RE, Dorsey DA, Beaudet LN, Parvin CA, Zhang W, Sima AA. Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy. J Neuropathol Exp Neurol 2004; 63: 450-460
121. Spangeus A, El-Salhy M. Myenteric plexus of obese diabetic mice (an animal model of human type 2 diabetes). Histol Histopathol 2001; 16: 159-165
122. Thomson AB, Keelan M, Thiesen A, Clandinin MT, Ropeleski M, Wild GE. Small bowel review: diseases of the small intestine. Dig Dis Sci 2001; 46: 2555-2566
123. Tomlinson DR, Carrington AL, Diemel LT, Ettlinger CB, Smith WJ, Fernyhough P. Limitations of the polyol hypothesis in the pathobiology of experimental diabetic neuropathy. Diabet Med 1993; 10 Suppl 2: 27S-30S
124. Coulie B, Tack J, Sifrim D, Andrioli A, Janssens J. Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am J Physiol 1999; 276: G373-G377
125. Russo A, Fraser R, Adachi K, Horowitz M, Boeckxstaens G. Evidence that nitric oxide mechanisms regulate small intestinal motility in humans. Gut 1999; 44: 72-76
126. Wrzos HF, Cruz A, Polavarapu R, Shearer D, Ouyang A. Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats. Dig Dis Sci 1997; 42: 2106-2110
127. Yagihashi S, Kamijo M, Ido Y, Mirrlees DJ. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats. Diabetes 1990; 39: 690-696
128. Undeland KA, Hausken T, Aanderud S, Berstad A. Lower postprandial gastric volume response in diabetic patients with vagal neuropathy. Neurogastroenterol Motil 1997; 9: 19-24
129. Lluch I, Ascaso JF, Mora F, Minguez M, Pena A, Hernandez A, Benages A. Gastroesophageal reflux in diabetes mellitus. Am J Gastroenterol 1999; 94: 919-924
130. Bharucha AE, Camilleri M, Low PA, Zinsmeister AR. Autonomic dysfunction in gastrointestinal motility disorders. Gut 1993; 34: 397-401
131. Vinik AI, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 2001; 68: 928-30, 932, 934-944
132. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579
133. Kelkar P. Diabetic neuropathy. Semin Neurol 2005; 25: 168-173
134. Eckersley L. Role of the Schwann cell in diabetic neuropathy. Int Rev Neurobiol 2002; 50: 293-321
135. Cellek S, Foxwell NA, Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2003; 52: 2353-2362
136. Cellek S, Qu W, Schmidt AM, Moncada S. Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. Diabetologia 2004; 47: 331-339
137. King RH. The role of glycation in the pathogenesis of diabetic polyneuropathy. Mol Pathol 2001; 54: 400-408
138. Iyer SK, Chandrasekhara KL, Sutton A. Diffuse muscular hypertrophy of esophagus. Am J Med 1986; 80: 849-852
139. Watanabe T, Asanuma A, Tanaka M, Akiba T, Koga T. Morphological study on the gastric mucosa in diabetes mellitus rats induced by streptozotocin Exp Anim 1995; 43: 693-696
140. Forster J, Damjanov I, Lin Z, Sarosiek I, Wetzel P, McCallum RW. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 2005; 9: 102-108
141. Horvath VJ, Vittal H, Ordog T. Reduced insulin and IGF-I signaling, not hyperglycemia, underlies the diabetes-associated depletion of interstitial cells of Cajal in the murine stomach. Diabetes 2005; 54: 1528-1533
142. Long QL, Fang DC, Shi HT, Luo YH. Gastro-electric dysrhythm and lack of gastric interstitial cells of cajal. World J Gastroenterol 2004; 10: 1227-1230
143. Ejskjaer NT, Bradley JL, Buxton-Thomas MS, Edmonds ME, Howard ER, Purewal T, Thomas PK, Watkins PJ. Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 1999; 16: 488-495
144. He CL, Soffer EE, Ferris CD, Walsh RM, Szurszewski JH, Farrugia G. Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001; 121: 427-434
145. Secondulfo M, Iafusco D, Carratu R, deMagistris L, Sapone A, Generoso M, Mezzogiomo A, Sasso FC, Carteni M, De Rosa R, Prisco F, Esposito V. Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Dig Liver Dis 2004; 36: 35-45
146. Bhor VM, Raghuram N, Sivakami S. Oxidative damage and altered antioxidant enzyme activities in the small intestine of streptozotocin-induced diabetic rats. Int J Biochem Cell Biol 2004; 36: 89-97
147. Noda T, Iwakiri R, Fujimoto K, Yoshida T, Utsumi H, Sakata H, Hisatomi A, Aw TY. Suppression of apoptosis is responsible for increased thickness of intestinal mucosa in streptozotocin-induced diabetic rats. Metabolism 2001; 50: 259-264
148. Tormo MA, Martinez IM, Romero de Tejada A, Gil-Exojo I, Campillo JE. Morphological and enzymatic changes of the small intestine in an n0-STZ diabetes rat model. Exp Clin Endocrinol Diabetes 2002; 110: 119-123
149. Adachi T, Mori C, Sakurai K, Shihara N, Tsuda K, Yasuda K. Morphological changes and increased sucrase and isomaltase activity in small intestines of insulin-deficient and type 2 diabetic rats. Endocr J 2003; 50: 271-279
150. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001; 44: 129-146
151. Monnier VM, Sell DR, Nagaraj RH, Miyata S, Grandhee S, Odetti P, Ibrahim SA. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 1992; 41 Suppl 2: 36-41
152. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001; 56: 1-21
153. Sanchez SS, Genta SB, Aybar MJ, Honore SM, Villecco EI, Sanchez Riera AN. Changes in the expression of small intestine extracellular matrix proteins in streptozotocin-induced diabetic rats. Cell Biol Int 2000; 24: 881-888
154. Reddy GK. AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc Res 2004; 68: 132-142
155. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005, 83: 876-886
156. Stern DM, Yan SD, Yan SF, Schmidt AM. Receptor for advanced glycation endproducts; (RAGE) and the complications of diabetes. Ageing Res Rev 2002; 1: 1-15
157. Wautier JL, Zoukourian C, Chappey O, Wautier MP, Guillausseau PJ, Cao R, Hori O, Stern D, Schmidt AM. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 1996; 97: 238-243
158. Patterson LM, Zheng H, Ward SM, Berthoud HR. Vanilloid receptor (VR1) expression in vagal afferent neurons innervating the gastrointestinal tract. Cell Tissue Res 2003; 311: 277-287
159. Phillips RJ, Powley TL. Tension and stretch receptors in gastrointestinal smooth muscle: re-evaluating vagal mechanoreceptor electrophysiology. Brain Res Brain Res Rev 2000; 34: 1-26
160. Raab M, Neuhuber WL. Intraganglionic laminar endings and their relationships with neuronal and glial structures of myenteric ganglia in the esophagus of rat and mouse. Histochem Cell Biol 2004; 122: 445-459
161. Raab M, Neuhuber WL. Number and distribution of intraganglionic laminar endings in the mouse esophagus as demonstrated with two different immunohistochemical markers. J Histochem Cytochem 2005; 53: 1023-1031
162. Swithers SE, Baronowsky E, Powley TL. Vagal intraganglionic laminar endings and intramuscular arrays mature at different rates in pre-weanling rat stomach. Auton Neurosci 2002; 102: 13-19
163. Zagorodnyuk VP, Chen BN, Brookes SJ. Intraganglionic laminar endings are mechano-transduction sites of vagal tension receptors in the guinea-pig stomach. J Physiol 2001; 534: 255-268
164. Zagorodnyuk VP, Chen BN, Costa M, Brookes SJ. Mechanotransduction by intraganglionic laminar endings of vagal tension receptors in the guinea-pig oesophagus. J Physiol 2003; 553: 575-587
165. Zagorodnyuk VP, Lynn P, Costa M, Brookes SJ. Mechanisms of mechanotransduction by specialized low-threshold mechanoreceptors in the guinea pig rectum. Am J Physiol Gastrointest Liver Physiol 2005; 289: G397-G406
166. Gregersen H. Biomechanics of the Gastrointestinal Tract. London: Springer-Verlag; 2002
167. Pedersen J, Gao C, Egekvist H, Bjerring P, Arendt-Nielsen L, Gregersen H, Drewes AM. Pain and biomechanical responses to distention of the duodenum in patients with systemic sclerosis. Gastroenterology 2003; 124: 1230-1239
168. Drewes AM, Gregersen H, Arendt-Nielsen L. Experimental pain in gastroenterology: a reappraisal of human studies. Scand J Gastroenterol 2003; 38: 1115-1130
169. Drewes AM, Schipper KP, Dimcevski G, Petersen P, Andersen OK, Gregersen H, Arendt-Nielsen L. Multimodal assessment of pain in the esophagus: a new experimental model. Am J Physiol Gastrointest Liver Physiol 2002; 283: G95-G103
170. Pedersen J, Reddy H, Funch-Jensen P, Arendt-Nielsen L, Gregersen H, Drewes AM. Cold and heat pain assessment of the human oesophagus after experimental sensitisation with acid. Pain 2004; 110: 393-399
171. Drewes AM, Pedersen J, Liu W, Arendt-Nielsen L, Gregersen H. Controlled mechanical distension of the human oesophagus: sensory and biomechanical findings. Scand J Gastroenterol 2003; 38: 27-35
172. Frokjaer JB, Andersen SD, Gale J, Arendt-Nielsen L, Gregersen H, Drewes AM. An experimental study of viscero-visceral hyperalgesia using an ultrasound-based multimodal sensory testing approach. Pain 2005; 119: 191-200
173. Pedersen J, Drewes AM, Gregersen H. New analysis for the study of the muscle function in the human oesophagus. Neurogastroenterol Motil 2005; 17: 767-772